Cite
Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases.
MLA
Saida, Yu, et al. “Efficacy of EGFR‐TKIs with or without Upfront Brain Radiotherapy for EGFR‐mutant NSCLC Patients with Central Nervous System Metastases.” Thoracic Cancer, vol. 10, no. 11, Nov. 2019, pp. 2106–16. EBSCOhost, https://doi.org/10.1111/1759-7714.13189.
APA
Saida, Y., Watanabe, S., Abe, T., Shoji, S., Nozaki, K., Ichikawa, K., Kondo, R., Koyama, K., Miura, S., Tanaka, H., Okajima, M., Terada, M., Ishida, T., Tsukada, H., Makino, M., Iwashima, A., Sato, K., Matsumoto, N., Yoshizawa, H., & Kikuchi, T. (2019). Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases. Thoracic Cancer, 10(11), 2106–2116. https://doi.org/10.1111/1759-7714.13189
Chicago
Saida, Yu, Satoshi Watanabe, Tetsuya Abe, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, et al. 2019. “Efficacy of EGFR‐TKIs with or without Upfront Brain Radiotherapy for EGFR‐mutant NSCLC Patients with Central Nervous System Metastases.” Thoracic Cancer 10 (11): 2106–16. doi:10.1111/1759-7714.13189.